Ali Abdelfattah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ali Abdelfattah has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Alhomidi Almotiri
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Kingdom of Saudi Arabia AND European Cancer Stem Cell Research Institute, Cardiff University, School of Biosciences, Cardiff, United Kingdom
7 shared publications - Neil P. Rodrigues
European Cancer Stem Cell Research Institute, Cardiff University, School of Biosciences, Cardiff, UK
5 shared publications - Khaldun Jacoub
Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, Jordan
3 shared publications - Alex Tonks
Department of Hematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK
2 shared publications Ghufran S. Issa
Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences The Hashemite University Zarqa Jordan
2 shared publicationsJuan Bautista Menendez-Gonzalez
European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Cardiff, United Kingdom
2 shared publications
Latest Publications
- 27 July 2026
- Published by Wiley in European Journal of Haematology
- Vol. 117 (5) , 1338-1346
Characteristics and Risk Factors of Thrombotic Complications in Patients With Iron Deficiency Anemia
Background/Objective: Although thromboses in association with iron deficiency anemia (IDA) have been reported in several case reports, comprehensive studies investigating the incidence, characteristics, and risk factors of thrombosis in this population remain limited. Herein, we sought to characterize the clinical features of thrombosis occurring in IDA patients and to identify potential risk factors contributing to thrombosis development in this context. Methods: This retrospective study included 329 IDA patients and 150 healthy controls. Medical records were evaluated for CBC, iron profiles, and incidence of thrombosis. Inflammatory biomarkers were calculated from baseline CBC, including ratios of neutrophil‐to‐lymphocyte (NLR), monocyte‐to‐lymphocyte (MLR), platelet‐to‐lymphocyte (PLR), systemic inflammatory index (SII), systemic inflammatory response‐index (SIRI), and aggregate‐index of systemic inflammation (AISI). IDA patients were stratified based on thrombosis progression. Results: Among IDA patients, 62 patients (18.85%) developed post‐diagnosis thrombotic events (15.20% arterial and 3.65% venous), and the estimated 10‐year thrombotic event‐free survival rate was 73.56%. Arterial events were mostly ischemic heart diseases ( n = 29, 8.81%). IDA patients with thrombotic progression showed a significant increase in NLR, MLR, PLR, SII, AISI, and SIRI compared to healthy controls. IDA patients with thrombotic progression revealed significantly higher WBC counts, neutrophils, monocytes, NLP, MLR, AISI, SIRI, older age, and a prior history of thrombosis compared to IDA patients without thrombotic events. Multivariate logistic regression analysis unveiled that age, previous history of thrombosis, and leukocytosis were independent risk factors for thrombosis progression in IDA patients. Conclusion: The study characterizes thrombotic events in IDA patients and underpins evidence connecting systemic inflammation to thrombosis progression, highlighting the importance of effective management of this common disorder.
- 27 July 2026
- Published by Wiley in European Journal of Haematology
- Vol. 117 (5) , 1338-1346
Characteristics and Risk Factors of Thrombotic Complications in Patients With Iron Deficiency Anemia
Background/Objective: Although thromboses in association with iron deficiency anemia (IDA) have been reported in several case reports, comprehensive studies investigating the incidence, characteristics, and risk factors of thrombosis in this population remain limited. Herein, we sought to characterize the clinical features of thrombosis occurring in IDA patients and to identify potential risk factors contributing to thrombosis development in this context. Methods: This retrospective study included 329 IDA patients and 150 healthy controls. Medical records were evaluated for CBC, iron profiles, and incidence of thrombosis. Inflammatory biomarkers were calculated from baseline CBC, including ratios of neutrophil‐to‐lymphocyte (NLR), monocyte‐to‐lymphocyte (MLR), platelet‐to‐lymphocyte (PLR), systemic inflammatory index (SII), systemic inflammatory response‐index (SIRI), and aggregate‐index of systemic inflammation (AISI). IDA patients were stratified based on thrombosis progression. Results: Among IDA patients, 62 patients (18.85%) developed post‐diagnosis thrombotic events (15.20% arterial and 3.65% venous), and the estimated 10‐year thrombotic event‐free survival rate was 73.56%. Arterial events were mostly ischemic heart diseases ( n = 29, 8.81%). IDA patients with thrombotic progression showed a significant increase in NLR, MLR, PLR, SII, AISI, and SIRI compared to healthy controls. IDA patients with thrombotic progression revealed significantly higher WBC counts, neutrophils, monocytes, NLP, MLR, AISI, SIRI, older age, and a prior history of thrombosis compared to IDA patients without thrombotic events. Multivariate logistic regression analysis unveiled that age, previous history of thrombosis, and leukocytosis were independent risk factors for thrombosis progression in IDA patients. Conclusion: The study characterizes thrombotic events in IDA patients and underpins evidence connecting systemic inflammation to thrombosis progression, highlighting the importance of effective management of this common disorder.
- 10 November 2025
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 48 (2) , 305-315
Monocyte‐To‐Lymphocyte Ratio as a Predictor of Thrombosis Progression in Patients With Polycythemia Vera: A Retrospective Study
Introduction: Thrombosis is a leading cause of mortality in polycythemia vera (PV), yet little is known about early predictors of thrombosis progression. Emerging evidence links systemic inflammation to thrombosis risk. This study assessed hematological inflammatory parameters, including the neutrophil‐to‐lymphocyte ratio (NLR), monocyte‐to‐lymphocyte ratio (MLR), platelet‐to‐lymphocyte ratio (PLR), systemic immune‐inflammation index (SII), systemic inflammatory response index (SIRI), and aggregate index of systemic inflammation (AISI), for their utility in predicting thrombosis progression in PV. Methods: This retrospective study analyzed 102 PV patients (2008–2024) and 115 healthy controls. Clinical and laboratory data, including thrombotic events, were examined. Patients were stratified into low‐and high‐risk groups, further categorized by thrombosis progression. Inflammatory biomarkers were derived from baseline blood counts. Results: Median follow‐up was 51 months, the 10‐year thrombotic events‐free survival rate was 84.30%, and 21 patients (20.59%) showed thrombosis progression. PV patients had higher NLR, MLR, PLR, SII, SIRI, and AISI than controls. NLR, MLR, SIRI, and AISI were associated with an increased risk of thrombosis compared to the low‐risk group. In the progression group, high monocytes, NLR, MLR, SIRI, AISI, and previous thrombosis were notably correlated. ROC analysis showed that MLR (AUC = 0.739), SIRI (AUC = 0.714), AISI (AUC = 0.670), and NLR (AUC = 0.649) had the highest predictive ability for thrombosis progression. Multivariate analysis identified MLR (HR = 6.979) and previous thrombosis (HR = 4.494) as independent risk factors. Conclusion: These findings support recent reports linking systemic inflammation to thrombosis risk in PV patients and highlight for the first time that MLR may serve as a valuable prognostic biomarker for thrombotic events.
- 10 November 2025
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 48 (2) , 305-315
Monocyte‐To‐Lymphocyte Ratio as a Predictor of Thrombosis Progression in Patients With Polycythemia Vera: A Retrospective Study
Introduction: Thrombosis is a leading cause of mortality in polycythemia vera (PV), yet little is known about early predictors of thrombosis progression. Emerging evidence links systemic inflammation to thrombosis risk. This study assessed hematological inflammatory parameters, including the neutrophil‐to‐lymphocyte ratio (NLR), monocyte‐to‐lymphocyte ratio (MLR), platelet‐to‐lymphocyte ratio (PLR), systemic immune‐inflammation index (SII), systemic inflammatory response index (SIRI), and aggregate index of systemic inflammation (AISI), for their utility in predicting thrombosis progression in PV. Methods: This retrospective study analyzed 102 PV patients (2008–2024) and 115 healthy controls. Clinical and laboratory data, including thrombotic events, were examined. Patients were stratified into low‐and high‐risk groups, further categorized by thrombosis progression. Inflammatory biomarkers were derived from baseline blood counts. Results: Median follow‐up was 51 months, the 10‐year thrombotic events‐free survival rate was 84.30%, and 21 patients (20.59%) showed thrombosis progression. PV patients had higher NLR, MLR, PLR, SII, SIRI, and AISI than controls. NLR, MLR, SIRI, and AISI were associated with an increased risk of thrombosis compared to the low‐risk group. In the progression group, high monocytes, NLR, MLR, SIRI, AISI, and previous thrombosis were notably correlated. ROC analysis showed that MLR (AUC = 0.739), SIRI (AUC = 0.714), AISI (AUC = 0.670), and NLR (AUC = 0.649) had the highest predictive ability for thrombosis progression. Multivariate analysis identified MLR (HR = 6.979) and previous thrombosis (HR = 4.494) as independent risk factors. Conclusion: These findings support recent reports linking systemic inflammation to thrombosis risk in PV patients and highlight for the first time that MLR may serve as a valuable prognostic biomarker for thrombotic events.
- Open Access
- 1 July 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (7) , 357-364
Association of ABO and Rhesus Blood Groups With Oral Cancers
The ABO and Rhesus blood systems have been studied extensively in relation to various diseases, including cancers. Recent evidence suggests that ABO blood group may influence susceptibility to oral potentially malignant disorders (OPMDs) and oral cancers, particularly oral squamous cell carcinoma (OSCC). The current review explores the association of ABO and Rhesus blood groups with oral cancers, summarizing epidemiological, molecular, and immunological studies to elucidate potential mechanisms underlying this relationship.
- 1 July 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (7) , 357-364
Open AccessAssociation of ABO and Rhesus Blood Groups With Oral Cancers
The ABO and Rhesus blood systems have been studied extensively in relation to various diseases, including cancers. Recent evidence suggests that ABO blood group may influence susceptibility to oral potentially malignant disorders (OPMDs) and oral cancers, particularly oral squamous cell carcinoma (OSCC). The current review explores the association of ABO and Rhesus blood groups with oral cancers, summarizing epidemiological, molecular, and immunological studies to elucidate potential mechanisms underlying this relationship.
- Open Access
- 23 June 2025
- Published by Elsevier in Acta Tropica
- Vol. 268, 107708
Genetic diversity and phylogenetic analysis of carbapenem-resistant Acinetobacter baumannii clinical isolates in Jordan
- 23 June 2025
- Published by Elsevier in Acta Tropica
- Vol. 268, 107708
Open AccessGenetic diversity and phylogenetic analysis of carbapenem-resistant Acinetobacter baumannii clinical isolates in Jordan
- Open Access
- 10 March 2025
- Published by JURUFRA SL in Retos
- Vol. 66, 754-765
The impact of Ramadan fasting on hematopoiesis, hematological inflammatory parameters, and metabolic processes among athletes
Introduction: Muslim athletes fast from dawn to sunset during the month of Ramadan, prompting research into how this fasting affects their physiology and performance. Objective: This study aimed to evaluate the impact of Ramadan fasting on anthropometric parameters, hematological and inflammatory markers, and metabolic processes in a cohort of athletes, given the inconsistent findings from previous studies and limited focus on immune system effects. Methodology: This research was conducted on 15 fasted Jordanian national players who maintained their regular training sessions. Anthropometry, blood elements, inflammatory parameters, lipid profiles, and kidney functions were measured the day before and the day after Ramadan fasting. Results: Analyses showed that weight, body fat mass, neutrophils, hematological inflammatory parameters, cholesterol, triglyceride, and low-density lipoprotein were significantly lower after Ramadan fasting; body mass index, body fat percentage, lean body mass, and blood volume displayed a trend of reduction, while lymphocytes were significantly higher. There were no changes in erythrocyte indices and kidney function tests. Conclusion: These findings indicate that Ramadan fasting leads to weight loss, improved cardiovascular health, and modification in immune response dynamics in athletes. Further studies are required to elucidate the mechanisms underlying these effects.
- 10 March 2025
- Published by JURUFRA SL in Retos
- Vol. 66, 754-765
Open AccessThe impact of Ramadan fasting on hematopoiesis, hematological inflammatory parameters, and metabolic processes among athletes
Introduction: Muslim athletes fast from dawn to sunset during the month of Ramadan, prompting research into how this fasting affects their physiology and performance. Objective: This study aimed to evaluate the impact of Ramadan fasting on anthropometric parameters, hematological and inflammatory markers, and metabolic processes in a cohort of athletes, given the inconsistent findings from previous studies and limited focus on immune system effects. Methodology: This research was conducted on 15 fasted Jordanian national players who maintained their regular training sessions. Anthropometry, blood elements, inflammatory parameters, lipid profiles, and kidney functions were measured the day before and the day after Ramadan fasting. Results: Analyses showed that weight, body fat mass, neutrophils, hematological inflammatory parameters, cholesterol, triglyceride, and low-density lipoprotein were significantly lower after Ramadan fasting; body mass index, body fat percentage, lean body mass, and blood volume displayed a trend of reduction, while lymphocytes were significantly higher. There were no changes in erythrocyte indices and kidney function tests. Conclusion: These findings indicate that Ramadan fasting leads to weight loss, improved cardiovascular health, and modification in immune response dynamics in athletes. Further studies are required to elucidate the mechanisms underlying these effects.
- Open Access
- 30 May 2024
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 18 (05) , 839-842
Coexistence of Helicobacter pylori and Giardia duodenalis causes severe iron deficiency anaemia in an adult male: a case report
Introduction: Iron deficiency anaemia (IDA), the most prevalent type of anaemia, is recognised as a significant global health concern that affects individuals of all ages. Case Presentation: Herein, we present a case involving an adult male coinfected with Helicobacter pylori and Giardia duodenalis, which precipitated severe IDA. Results: A 24-year-old male presented with symptoms including fatigue, dizziness, headache, abdominal pain, and diarrhoea persisting for four weeks. Thorough blood tests, including complete blood counts, blood film, and iron studies, conclusively established the presence of severe IDA. Furthermore, his faecal sample was collected and subjected to analysis of common bacterial and parasitic gastrointestinal infections. Examination of upper and lower gastrointestinal pathogens indicated that the severe IDA was most likely a result of coinfection with H. pylori and G. duodenalis. The patient received treatment involving antibiotics and iron replacement therapy, which resulted in an improvement in both his symptoms and laboratory results. Conclusions: The present report provides crucial insights into the synergistic effect of concurrent H. pylori and G. duodenalis infections, highlighting their potential to induce severe IDA in infected patients.
- 30 May 2024
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 18 (05) , 839-842
Open AccessCoexistence of Helicobacter pylori and Giardia duodenalis causes severe iron deficiency anaemia in an adult male: a case report
Introduction: Iron deficiency anaemia (IDA), the most prevalent type of anaemia, is recognised as a significant global health concern that affects individuals of all ages. Case Presentation: Herein, we present a case involving an adult male coinfected with Helicobacter pylori and Giardia duodenalis, which precipitated severe IDA. Results: A 24-year-old male presented with symptoms including fatigue, dizziness, headache, abdominal pain, and diarrhoea persisting for four weeks. Thorough blood tests, including complete blood counts, blood film, and iron studies, conclusively established the presence of severe IDA. Furthermore, his faecal sample was collected and subjected to analysis of common bacterial and parasitic gastrointestinal infections. Examination of upper and lower gastrointestinal pathogens indicated that the severe IDA was most likely a result of coinfection with H. pylori and G. duodenalis. The patient received treatment involving antibiotics and iron replacement therapy, which resulted in an improvement in both his symptoms and laboratory results. Conclusions: The present report provides crucial insights into the synergistic effect of concurrent H. pylori and G. duodenalis infections, highlighting their potential to induce severe IDA in infected patients.
- 29 May 2024
- Published by Springer Nature in Parasitology Research
- Vol. 123 (5) , 1-8
An overview of qualitative and quantitative platelet abnormalities in schistosomiasis
Schistosomiasis is a neglected tropical disease referring to the infection with blood parasitic trematodes of the genus Schistosoma. It impacts millions of people worldwide, primarily in low-to-middle-income countries. Patients infected with schistosomiasis often exhibit a distinct hematological profile, including anemia, eosinophilia, thrombocytopenia, and coagulopathy. Platelets, essential components of the hemostatic system, play a crucial role in the pathogenesis of schistosomiasis. Schistosomes secrete serine proteases and express ectoenzymes, such as calpain protease, alkaline phosphatase (SmAP), phosphodiesterase (SmNPP5), ATP diphosphohydrolase (SmATPDase1), serine protease Sk1, SmSP2, and Sm22.6, which can interfere with platelet normal functioning. This report provides comprehensive, up-to-date information on platelet abnormalities observed in patients with schistosomiasis, highlighting their importance in the disease progression and complications. It delves into the interactions between platelets and schistosomes, including the impact of platelet dysfunction on hemostasis and immune responses, immune-mediated platelet destruction, and the potential mechanisms by which schistosome tegumental ectoenzymes affect platelets. Furthermore, the report clarifies the relationship between platelet abnormalities and clinical manifestations such as thrombocytopenia, coagulation disorders, and the emergence of portal hypertension and gastrointestinal bleeding. Understanding the complex interplay between platelets and schistosomes is crucial for improving patient management and outcomes in schistosomiasis, particularly for those with platelet alterations. This knowledge contributes to improved diagnostic methods, innovative treatment strategies, and global efforts to control and eliminate schistosomiasis.
- 29 May 2024
- Published by Springer Nature in Parasitology Research
- Vol. 123 (5) , 1-8
An overview of qualitative and quantitative platelet abnormalities in schistosomiasis
Schistosomiasis is a neglected tropical disease referring to the infection with blood parasitic trematodes of the genus Schistosoma. It impacts millions of people worldwide, primarily in low-to-middle-income countries. Patients infected with schistosomiasis often exhibit a distinct hematological profile, including anemia, eosinophilia, thrombocytopenia, and coagulopathy. Platelets, essential components of the hemostatic system, play a crucial role in the pathogenesis of schistosomiasis. Schistosomes secrete serine proteases and express ectoenzymes, such as calpain protease, alkaline phosphatase (SmAP), phosphodiesterase (SmNPP5), ATP diphosphohydrolase (SmATPDase1), serine protease Sk1, SmSP2, and Sm22.6, which can interfere with platelet normal functioning. This report provides comprehensive, up-to-date information on platelet abnormalities observed in patients with schistosomiasis, highlighting their importance in the disease progression and complications. It delves into the interactions between platelets and schistosomes, including the impact of platelet dysfunction on hemostasis and immune responses, immune-mediated platelet destruction, and the potential mechanisms by which schistosome tegumental ectoenzymes affect platelets. Furthermore, the report clarifies the relationship between platelet abnormalities and clinical manifestations such as thrombocytopenia, coagulation disorders, and the emergence of portal hypertension and gastrointestinal bleeding. Understanding the complex interplay between platelets and schistosomes is crucial for improving patient management and outcomes in schistosomiasis, particularly for those with platelet alterations. This knowledge contributes to improved diagnostic methods, innovative treatment strategies, and global efforts to control and eliminate schistosomiasis.
- Open Access
- 8 February 2024
- Published by Elsevier in Experimental Hematology
- Vol. 134, 104177
Zeb1 maintains long-term adult hematopoietic stem cell function and extramedullary hematopoiesis
- 8 February 2024
- Published by Elsevier in Experimental Hematology
- Vol. 134, 104177
Open AccessZeb1 maintains long-term adult hematopoietic stem cell function and extramedullary hematopoiesis
- Open Access
The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas
Lymphomas are heterogeneous malignant tumours of white blood cells characterised by the aberrant proliferation of mature lymphoid cells or their precursors. Lymphomas are classified into main types depending on the histopathologic evidence of biopsy taken from an enlarged lymph node, progress stages, treatment strategies, and outcomes: Hodgkin and non-Hodgkin lymphoma (NHL). Moreover, lymphomas can be further divided into subtypes depending on the cell origin, and immunophenotypic and genetic aberrations. Many factors play vital roles in the progression, pathogenicity, incidence, and mortality rate of lymphomas. Among NHLs, peripheral T cell lymphomas (PTCLs) are rare lymphoid malignancies, that have various cellular morphology and genetic mutations. The clinical presentations are usually observed at the advanced stage of the disease. Many recent studies have reported that the expressions of NOTCH1, GATA3, and c-MYC are associated with poorer prognosis in PTCL and are involved in downstream activities. However, questions have been raised about the pathological relationship between these factors in PTCLs. Therefore, in this review, we investigate the role and relationship of the NOTCH1 pathway, transcriptional factor GATA3 and proto-oncogene c-MYC in normal T cell development and malignant PTCL subtypes.
Open AccessThe Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas
Lymphomas are heterogeneous malignant tumours of white blood cells characterised by the aberrant proliferation of mature lymphoid cells or their precursors. Lymphomas are classified into main types depending on the histopathologic evidence of biopsy taken from an enlarged lymph node, progress stages, treatment strategies, and outcomes: Hodgkin and non-Hodgkin lymphoma (NHL). Moreover, lymphomas can be further divided into subtypes depending on the cell origin, and immunophenotypic and genetic aberrations. Many factors play vital roles in the progression, pathogenicity, incidence, and mortality rate of lymphomas. Among NHLs, peripheral T cell lymphomas (PTCLs) are rare lymphoid malignancies, that have various cellular morphology and genetic mutations. The clinical presentations are usually observed at the advanced stage of the disease. Many recent studies have reported that the expressions of NOTCH1, GATA3, and c-MYC are associated with poorer prognosis in PTCL and are involved in downstream activities. However, questions have been raised about the pathological relationship between these factors in PTCLs. Therefore, in this review, we investigate the role and relationship of the NOTCH1 pathway, transcriptional factor GATA3 and proto-oncogene c-MYC in normal T cell development and malignant PTCL subtypes.